Tagging SNPs in the MTHFR gene and risk of ischemic stroke in a Chinese population

International Journal of Molecular Sciences

Volumn 15, Issue 5, 2014, Pages 8931-8940

  Zhou, Bao Sheng ^a   Bu, Guo Yun ^b   Li, Mu ^a   Chang, Bin Ge ^a   Zhou, Yi Pin ^c  

^a TIANJIN FIRST CENTRAL HOSPITAL   (China)

^b TIANJIN HOSPITAL   (China)

^c TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

Homocysteine; Ischemic stroke; MTHFR; Polymorphism

Indexed keywords

5, 10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE; GENE FREQUENCY; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MTHFR GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINA; GENETICS; GENOTYPE; ODDS RATIO; PATHOLOGY;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 84901303119     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15058931     Document Type: Article

References (34)

1. Johnston, S.C.; Mendis, S.; Mathers, C.D. Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009, 8, 345-354.
2. Feigin, V.L.; Lawes, C.M.; Bennett, D.A.; Barker-Collo, S.L.; Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol. 2009, 8, 355-369.
3. Chen, Z. The mortality and death cause of national sample areas. In The Third National Survey on the Cause of Death, 1st ed.; Chen, Z., Ed.; Peking Union Medical University Press: Beijing, China, 2008; pp. 14-15.
4. Zhang, L.F.; Yang, J.; Hong, Z.; Yuan, G.G.; Zhou, B.F.; Zhao, L.C.; Huang, Y.N.; Chen, J.; Wu, Y.F. Proportion of different subtypes of stroke in China. Stroke 2003, 34, 2091-2096.
5. Yong, H.; Foody, J.; Linong, J.; Dong, Z.; Wang, Y.; Ma, L.; Meng, H.J.; Shiff, S.; Dayi, H. A systematic literature review of risk factors for stroke in China. Cardiol. Rev. 2013, 21, 77-93.
6. Shi, H.; Sheng, B.; Zhang, F.; Wu, C.; Zhang, R.; Zhu, J.; Xu, K.; Kuang, Y.; Jameson, S.C.; Lin, Z.; et al. Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am. J. Physiol. Heart Circ. Physiol. 2013, 304, H796-H805.
7. Perry, I.J.; Refsum, H.; Morris, R.W.; Ebrahim, S.B.; Ueland, P.M.; Shaper, A.G. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995, 346, 1395-1398.
8. Collaboration, H.S. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002, 288, 2015-2022.
9. Low, H.Q.; Chen, C.P.; Kasiman, K.; Thalamuthu, A.; Ng, S.S.; Foo, J.N.; Chang, H.M.; Wong, M.C.; Tai, E.S.; Liu, J. A comprehensive association analysis of homocysteine metabolic pathway genes in Singaporean Chinese with ischemic stroke. PLoS One 2011, 6, e24757.
10. Frosst, P.; Blom, H.J.; Milos, R.; Goyette, P.; Sheppard, C.A.; Boers, G.J.; den Heijer, M.; Kluijtmans, L.A.; van den Heuvel, L.P.; Rozen, R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase, Nat. Genet. 1995, 10, 111-113.
11. Shahzad, K.; Hai, A.; Ahmed, A.; Kizilbash, N.; Alruwaili, J. A structured-based model for the decreased activity of Ala222Val and Glu429Ala methylenetetrahydrofolate reductase (MTHFR) mutants. Bioinformation 2013, 9, 929-936.
12. Larsson, S.C.; Giovannucci, E.; Wolk, A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: A meta-analysis. Gastroenterology 2006, 131, 1271-1283.
13. Yang, S.; Zhang, J.; Feng, C.; Huang, G. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: A meta-analysis. Metabolism 2012, 62, 586-594.
14. Marosi, K.; Agota, A.; Végh, V.; Joó, J.G.; Langmár, Z.; Kriszbacher, I.; Nagy, Z.B. The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension. Orvosi Hetil. 2012, 153, 445-453.
15. Ye, H.; Yan, J.T.; Shao, J.M.; Zhang, F.; Hong, M.L.; Wang, D.W. A case-control study on the relationship between stroke and serum homocysteine level and the mutation of MTHFR gene. Zhonghua Liu Xing Bing Xue Za Zhi 2004, 25, 958-961.
16. Shi, C.; Kang, X.; Wang, Y.; Zhou, Y. The coagulation factor V Leiden, MTHFR C677T variant and eNOS 4ab polymorphism in young Chinese population with ischemic stroke. Clin. Chim. Acta 2008, 396, 7-9.
17. Li, C.M.; Zhang, C.; Lu, X.L.; Feng, H.Y.; Su, Q.X.; Zeng, Y.; Zhang, H.L.; Qiu, S.L. Relationship between methylenetrahydrofolate reductase gene and ischemic stroke. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006, 18, 264-267.
18. Gao, X.; Yang, H.; Teng, Z. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci. Lett. 2006, 398, 172-177.
19. Wu, J.M.; Wang, T.G.; Li, Y.Q.; Song, X.W.; Liu, Y.Y.; Yun, H.R.; Zhong, Z.Y.; Zhou, T.H. Genetic mutations of homocysteine metabolism related enzymes in patients with ischemic stroke. Yi Chuan 2004, 26, 298-302.
20. Jacques, P.F.; Bostom, A.G.; Williams, R.R.; Ellison, R.C.; Eckfeldt, J.H.; Rosenberg, I.H.; Selhub, J.; Rozen, R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996, 93, 7-9.
21. Zhao, X.; Jiang, H. Quantitative assessment of the association between MTHFR C677T polymorphism and hemorrhagic stroke risk. Mol. Biol. Rep. 2013, 40, 573-578.
22. Hamzi, K.; Tazzite, A.; Nadifi, S. Large-scale meta-analysis of genetic studies in ischemic stroke: Five genes involving 152,797 individuals. Indian J. Hum. Genet. 2011, 17, 212-217.
23. McColgan, P.; Sharma, P. The genetics of carotid dissection: Meta-analysis of a MTHFR/C677T common molecular variant. Cerebrovasc. Dis. 2008, 25, 561-565.
24. Somarajan, B.I.; Kalita, J.; Mittal, B.; Misra, U.K. Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients. A case-control study in a Northern Indian population. J. Neurol. Sci. 2011, 304, 67-70.
25. Kim, N.K.; Choi, B.O. MTHFR A1298C gene polymorphism: Independent risk factor for ischemic stroke? Korean Neurol. Assoc. J. 2003, 21, 606-613.
26. Han, I.B.; Kim, O.J.; Ahn, J.Y.; Oh, D.; Hong, S.P.; Huh, R.; Chung, S.S.; Kim, N.K. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population. Yonsei Med. J. 2010, 51, 253-260.
27. Arsene, D.; Gǎinǎ, G.; Bǎlescu, C.; Ardeleanu, C. C677T and A1298C methylenetetrahydropholate reductase (MTHFR) polymorphisms as factors involved in ischemic stroke. Rom. J. Morphol. Embryol. 2011, 52, 1203-1207.
28. Kumar, J.; Das, S.K.; Sharma, P.; Karthikeyan, G.; Ramakrishnan, L.; Sengupta, S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J. Hum. Genet. 2005, 50, 655-663.
29. Narayanan, S.; McConnell, J.; Little, J.; Sharp, L.; Piyathilake, C.J.; Powers, H.; Basten, G.; Duthie, S.J. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol. Biomark. Prev. 2004, 13, 1436-1443.
30. Swartz, M.D.; Peterson, C.B.; Lupo, P.J.; Wu, X.; Forman, M.R.; Spitz, M.R.; Hernandez, L.M.; Vannucci, M.; Shete, S. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One 2013, 8, e53475.
31. Yoshimi, A.; Aleksic, B.; Kawamura, Y.; Takahashi, N.; Yamada, S.; Usui, H.; Saito, S.; Ito, Y.; Iwata, N.; Inada, T.; et al. Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data. Schizophr. Res. 2010, 124, 216-222.
32. Marti, F.; Vollenweider, P.; Marques-Vidal, P.M.; Mooser, V.; Waeber, G.; Paccaud, F.; Bochud, M. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health. 2011, 11, 733.
33. Barrett, J.C.; Fry, B.; Maller, J.; Daly, M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21, 263-265.
34. Lin, D.Y.; Zeng, D.; Millikan, R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet. Epidemiol. 2005, 29, 299-312.